CARTaGENE is a public research platform of the CHU Sainte-Justine created to accelerate health research. CARTaGENE consists of both biological samples and health data from 43,000 Québec residents aged between 40 to 69 years.
Originally founded by Dr. Claude Laberge and Prof. Bartha Maria Knoppers, CARTaGENE is now under the scientific direction of Dr. Philippe Broët, Dr. Guillaume Lettre, and Dr. Simon Gravel.
Our health depends on a number of important factors including our environment, our lifestyle and our genes. Researchers have long been trying to establish the causes of chronic diseases that affect a large proportion of the population. So far, limited by the unavailability of genetic information or by the inability to obtain detailed information about the health and environmental risk exposure in the population, researchers have only been able to partly decipher the causes of these diseases. By being a catalyst for health innovation, CARTaGENE will enable to improve prevention, diagnosis and treatment of chronic diseases such as heart disease, diabetes and cancer. CARTaGENE will therefore contribute to the improvement of the Quebec healthcare system.